AXA S.A. - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 94 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
AXA S.A. ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2021$2,113,000
-39.5%
444,931
+1.2%
0.01%
-50.0%
Q3 2021$3,495,000
-40.8%
439,667
-48.2%
0.01%
+25.0%
Q2 2021$5,906,000
+75.9%
848,704
+100.2%
0.01%
-20.0%
Q1 2021$3,357,000
+3.0%
423,920
+2.4%
0.01%0.0%
Q4 2020$3,258,000
+50.6%
413,989
+35.7%
0.01%
+25.0%
Q3 2020$2,163,000305,1280.01%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Yu Fan 112,044$258,0003.49%
Aisling Capital Management LP 1,691,151$3,890,0002.10%
Sio Capital Management, LLC 871,101$2,004,0000.66%
Bain Capital Life Sciences Investors, LLC 2,847,689$6,550,0000.64%
Samsara BioCapital, LLC 883,720$2,033,0000.51%
Ghost Tree Capital, LLC 686,599$1,579,0000.34%
Nantahala Capital Management 3,200,593$7,361,0000.33%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 245,678$565,0000.29%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,059,894$9,338,0000.28%
Lion Point Capital, LP 300,000$690,0000.16%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders